Latest Schedule 13G passive stakes

Cystic Fibrosis Foundation reports a slight decrease in its beneficial ownership of BiomX Inc. common stock to 1.47%.

ExodusPoint Capital Management, LP, along with affiliated entities, has reported beneficial ownership of 1,004,155 shares, representing 4.7% of RE/MAX Holdings, Inc.'s Class A Common Stock.

Morgan Stanley has updated its beneficial ownership filing for Black Stone Minerals, L.P., reporting a total of 11,022,504 common units, representing 5.2% of the class.

Morgan Stanley has updated its beneficial ownership filing for Black Stone Minerals, L.P., reporting a total of 11,022,504 common units, representing 5.2% of the class.

RG.AI Technologies, Inc., Oedipus Inc., and Charles Eberly von Szecsey collectively report a 10.98% beneficial ownership stake in Swarmer, Inc. common stock, with a filing delay noted.

S.H.N. Financial Investments Ltd. has amended its Schedule 13G filing to reflect a revised beneficial ownership percentage of Tianci International, Inc. common stock, now standing at 9.99% after a stock split.

Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, has reported beneficial ownership of 722,280 shares of GAXOS.AI INC. common stock, representing 4.99% of the class.

Quantum X Labs Inc. has filed a Schedule 13G amendment detailing significant beneficial ownership changes by Nissim Daniel and J.B.D Innovation Ltd., including potential share acquisitions.

Point72 Asset Management, L.P., along with affiliated entities and Steven A. Cohen, has reported beneficial ownership of 5.0% of Viridian Therapeutics, Inc. common stock.

Amit Agarwal has reported a beneficial ownership of 690,000 shares, representing 3.79% of Cato Corp.'s Class A Common Stock, as of July 17, 2026.

Mark Edward Fischbach has reported beneficial ownership of 13,500,000 shares, representing 8.5% of GoPro, Inc.'s Class A Common Stock, as of July 13, 2026.

North Peak Capital Management, LLC and its affiliates have increased their beneficial ownership of GMR Solutions Inc. Class A common stock to 6.2%, acquiring an additional 3,375,609 shares.

Linden Capital Partners and associated entities have filed a Schedule 13G, reporting beneficial ownership of 6.3% of Thunder Bridge Capital Partners V, Ltd. Class A Ordinary Shares.

Jonathan Schechter has filed a Schedule 13G, reporting beneficial ownership of 71,256 shares, representing 9.9% of the outstanding common stock of 22nd Century Group, Inc.

Pau Hung To has reported the divestment of all previously held shares in Advanced Biomed Inc., resulting in zero beneficial ownership.

Pau Hung To has reported beneficial ownership of 176,225 shares, representing 12.75% of Advanced Biomed Inc.'s common stock, following a debt-for-equity exchange and subsequent stock splits.

Phoenix Financial Ltd. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of ICL Group Ltd. ordinary shares.

Joseph Reda and SEG Opportunity Fund, LLC have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 9.97% in 22nd Century Group, Inc.

Phoenix Financial Ltd. has updated its Schedule 13G filing, reporting a 4.6% beneficial ownership of Kamada Ltd.'s ordinary shares as of August 13, 2026.

Acorn Bioventures, L.P. and affiliated entities have reported an aggregate beneficial ownership of 12.1% in LeonaBio, Inc. following an amendment to their Schedule 13G filing.

Seah Chia Yee has acquired a 6.96% stake in Addentax Group Corp., holding 146,539 shares as of August 19, 2026.

Pinnacle Partners Inc. has disclosed beneficial ownership of 250,000 shares, representing 11.88% of Addentax Group Corp.'s common stock.

Hong Zhihao has reported beneficial ownership of 250,000 shares, representing 11.88% of Addentax Group Corp.'s common stock, as of August 19, 2026.

Bay Pond Investors (Bermuda) L.P. has reported beneficial ownership of over 5% of Redwood Trust, Inc.'s common stock.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have entered into a joint filing agreement concerning their beneficial ownership of Capricor Therapeutics, Inc. common stock.

Jorey Chernett has filed a Schedule 13G, reporting beneficial ownership of 2,339,009 American Depositary Shares, representing 19.6% of the outstanding class in Kazia Therapeutics Ltd.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.6% of Vanda Pharmaceuticals Inc. common stock.

William T. Walters, The Walters Group, and Susan B. Walters report a combined beneficial ownership of 18.8% in Zentalis Pharmaceuticals, Inc., reflecting shared voting and dispositive power.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.5% of T1 Energy Inc.'s common stock.

Daniel Louis Kaufman has reported beneficial ownership of 5,956,714 shares, representing 5.9% of Stereotaxis, Inc.'s common stock, as of August 12, 2026.